Home » Stocks » CMD

Cantel Medical Corporation (CMD)

Stock Price: $80.00 USD -0.35 (-0.44%)
Updated Jan 21, 2021 4:00 PM EST - Market closed
Market Cap 3.40B
Revenue (ttm) 1.06B
Net Income (ttm) 32.41M
Shares Out 42.16M
EPS (ttm) 0.76
PE Ratio 105.82
Forward PE 31.25
Dividend $0.21
Dividend Yield 0.26%
Trading Day January 21
Last Price $80.00
Previous Close $80.35
Change ($) -0.35
Change (%) -0.44%
Day's Open 80.13
Day's Range 79.46 - 80.47
Day's Volume 581,418
52-Week Range 21.76 - 84.66

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 week ago

WILMINGTON, Del., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Cantel Medical Corp. (“Cantel”) (NYSE: CMD) regarding possible breaches of fiduciary ...

Business Wire - 1 week ago

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cantel M...

Other stocks mentioned: STE
PRNewsWire - 1 week ago

NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in Ne...

Zacks Investment Research - 1 week ago

Does Cantel Medical (CMD) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 1 week ago

STERIS (STE) expects to strengthen and expand its endoscopy offerings along with extending into a new customer territory via the Cantel Medical buyout.

Other stocks mentioned: STE
PRNewsWire - 1 week ago

NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cantel Medical Corp. (NYSE: CMD) concerning ...

PRNewsWire - 1 week ago

NEW YORK, Jan. 12, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cantel Medical Corp. ("CMD" o...

PRNewsWire - 1 week ago

NEW YORK, Jan. 12, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Cantel Medical Corporation (NYSE: CMD) ("Cantel") and its board of directors con...

Other stocks mentioned: STE
Business Wire - 1 week ago

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether Cantel Medical Corp. (NYSE: CMD) and its board of directors violated the federal securi...

Market Watch - 1 week ago

Shares of Cantel Medical Corp. rose 1.8% in premarket trading Tuesday, after the infection prevention products company announced an agreement to be acquired by Ireland-based Steris PLC in a ca...

Other stocks mentioned: STE
Zacks Investment Research - 4 weeks ago

Top Ranked Momentum Stocks to Buy for December 23rd

Other stocks mentioned: BIDU, TSE
Zacks Investment Research - 1 month ago

Cantel (CMD) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Investment Research - 1 month ago

Top Ranked Momentum Stocks to Buy for December 21st

Other stocks mentioned: EVR, RIO
Zacks Investment Research - 1 month ago

Cantel (CMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Seeking Alpha - 1 month ago

Cantel Medical Corp. (CMD) CEO George Fotiades on Q1 2021 Results - Earnings Call Transcript

Benzinga - 1 month ago

iBio (NYSE: IBIO) shares are trading lower on Tuesday after the company announced a common stock offering. iBio's main area of business is plant-based protein expression technologies for vacci...

Other stocks mentioned: IBIO, STRO
The Motley Fool - 1 month ago

The company's latest quarterly earnings report managed to impress investors.

Zacks Investment Research - 1 month ago

Cantel (CMD) delivered earnings and revenue surprises of 150.00% and 1.55%, respectively, for the quarter ended October 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 1 month ago

Shares of Cantel Medical (NYSE:CMD) were unchanged in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 38.46% over the past year to $0.90, wh...

PRNewsWire - 1 month ago

LITTLE FALLS, N.J., Dec. 8, 2020 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its first quarter ended October 31, 2020. First quarter 2021 net sales w...

PRNewsWire - 1 month ago

LITTLE FALLS, N.J., Dec. 7, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) and Censis Technologies announced today a new long-term partnership to combine Cantel's leading infection preve...

Business Wire - 1 month ago

FRANKLIN, Tenn.--(BUSINESS WIRE)--Today, Censis Technologies, a wholly owned subsidiary of Fortive Corporation, and Cantel Medical Corp announced a new long-term partnership to combine Cantel'...

Zacks Investment Research - 1 month ago

Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 1 month ago

Cantel Medical has the legs to reach historical growth levels over the coming periods, backed by a strong Q4 performance. Q1 pre-announcements have indicated a stronger than expected sales rec...

Zacks Investment Research - 2 months ago

Cantel (CMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The Motley Fool - 2 months ago

COVID-19 has heightened the demand for companies that specialize in infection control.

Other stocks mentioned: JNJ, STE
GuruFocus - 3 months ago

The Covid-19 pandemic has given a significant boost to many industries such as manufacturers of gloves, masks, sanitizers, PPE (personal protective equipment), health insurance providers, and ...

Other stocks mentioned: CLX, ECL, KMB, NEOG, SNOA
PRNewsWire - 3 months ago

CHICAGO, Oct. 1, 2020 /PRNewswire/ -- HuFriedyGroup, the dental division of Cantel Medical Corp. (NYSE: CMD), and a global leader in infection prevention, dental instrument manufacturing, and ...

Seeking Alpha - 4 months ago

Cantel Medical Corp. (CMD) CEO George Fotiades on Q4 2020 Results - Earnings Call Transcript

Zacks Investment Research - 4 months ago

Cantel (CMD) delivered earnings and revenue surprises of 200.00% and 0.14%, respectively, for the quarter ended July 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 4 months ago

Shares of Cantel Medical (NYSE:CMD) moved higher by 4.9% in pre-market trading after the company reported Q4 results.

PRNewsWire - 4 months ago

LITTLE FALLS, N.J., Sept. 17, 2020 /PRNewswire/ -- Cantel Medical Corp.

Benzinga - 4 months ago

Cantel Medical (NYSE: CMD) announces its next round of earnings this Thursday, September 17.

Zacks Investment Research - 4 months ago

Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRNewsWire - 4 months ago

LITTLE FALLS, N.J., Sept. 3, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP.

PRNewsWire - 5 months ago

LITTLE FALLS, N.J., Aug. 6, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP.

PRNewsWire - 5 months ago

LITTLE FALLS, N.J., Aug. 3, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP.

Seeking Alpha - 7 months ago

Cantel Medical Corp. (CMD) CEO George Fotiades on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 7 months ago

Cantel (CMD) delivered earnings and revenue surprises of 14.29% and 0.54%, respectively, for the quarter ended April 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 7 months ago

Shares of Cantel Medical (NYSE:CMD) were flat in pre-market trading after the company reported Q3 results.

PRNewsWire - 7 months ago

LITTLE FALLS, N.J., June 4, 2020 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its third quarter ended April 30, 2020. Third quarter 2020 net sales wer...

Zacks Investment Research - 7 months ago

Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRNewsWire - 7 months ago

LITTLE FALLS, N.J., May 22, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) ("Cantel" or the "Company") today announced the sale of $28 million in aggregate principal amount of its 3.25% ...

The Motley Fool - 10 months ago

The medical device company missed Wall Street estimates in Q2 and lowered its full-year outlook in part due to the negative impact of the COVID-19 coronavirus.

Seeking Alpha - 10 months ago

Cantel Medical Corp. (CMD) CEO George Fotiades on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 10 months ago

Cantel (CMD) delivered earnings and revenue surprises of -10.29% and -1.60%, respectively, for the quarter ended January 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 10 months ago

Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 11 months ago

Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 11 months ago

Cantel Medical has taken the necessary steps to improve the business, and I expect to see earning growth similar to what it was in the past.

Seeking Alpha - 11 months ago

Expect insider filing volumes to increase again in the first week of February and stay strong through the end of March.

Other stocks mentioned: BTN, PNC, PPR, PSXP, SAFE

About CMD

Cantel Medical provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life ... [Read more...]

Industry
Medical Instruments & Supplies
Founded
1963
CEO
George Fotiades
Employees
3,669
Stock Exchange
NYSE
Ticker Symbol
CMD
Full Company Profile

Financial Performance

In 2020, Cantel Medical's revenue was $1.02 billion, an increase of 10.66% compared to the previous year's $918.16 million. Earnings were $13.71 million, a decrease of -75.10%.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for Cantel Medical stock is "Hold." The 12-month stock price forecast is 73.50, which is a decrease of -8.13% from the latest price.

Price Target
$73.50
(-8.13% downside)
Analyst Consensus: Hold